Physician profile
Marcus Zachariah
NPI 1477817187
$45,814.64
in general payments reported to CMS, 2019-2025
11 companies · $33K in 2025
The $33K reported for 2025 was more than what 93% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.77 · 2022: $178 · 2023: $590 · 2024: $12K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Food and Beverage: $2,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,000.00 |
| Food and Beverage | $2,601.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $42,422.75 | 2024-2025 | |
| Globus Medical, INC. | $1,144.16 | 2023-2025 | Alif Instruments (Universal), Excelsius Gps, Excelsius3d Imaging System |
| Aurora Spine, INC. | $1,000.00 | 2025 | Mega Plus Mis Spine System |
| Depuy Synthes Sales INC. | $310.95 | 2021-2023 | Expedium Verse, Viper |
| Abbott Laboratories | $170.10 | 2023-2024 | Infinity |
| Medtronic, INC. | $161.02 | 2024-2025 | Mazor X System, Medtronic Reusable Instruments |
| Integra Lifesciences Corporation | $158.06 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Stryker Corporation | $156.03 | 2024 | Everest Spinal System |
| Ebi, LLC | $135.72 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Boston Scientific Corporation | $130.63 | 2024 | Versacross Access Solution |
| Centinel Spine, LLC | $25.22 | 2023 | Fortos-C |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Zachariah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.